These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2612084)

  • 21. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis.
    Ravelli A; Di Fuccia G; Molinaro M; Ramenghi B; Zonta L; Regazzi MB; Martini A
    J Rheumatol; 1993 Sep; 20(9):1573-7. PubMed ID: 8164218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group.
    Ruperto N; Ravelli A; Falcini F; Lepore L; De Sanctis R; Zulian F; Buoncompagni A; Sardella ML; Strano C; Alessio M; Viola S; Martini A
    Ann Rheum Dis; 1998 Jan; 57(1):38-41. PubMed ID: 9536821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis.
    Ravelli A; Migliavacca D; Viola S; Ruperto N; Pistorio A; Martini A
    Clin Exp Rheumatol; 1999; 17(5):625-7. PubMed ID: 10544851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate.
    Rose CD; Fawcett PT; Gibney K; Doughty RA; Singsen BH
    Ann Rheum Dis; 1994 Jul; 53(7):471-4. PubMed ID: 7944621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study.
    van Dijkhuizen EH; Pouw JN; Scheuern A; Hügle B; Hardt S; Ganser G; Kümmerle-Deschner JB; Horneff G; Holzinger D; Bulatović Ćalasan M; Wulffraat NM
    Clin Exp Rheumatol; 2016; 34(1):148-54. PubMed ID: 26843067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth retardation in juvenile chronic arthritis patients treated with steroids.
    Falcini F; Taccetti G; Trapani S; Tafi L; Volpi M
    Clin Exp Rheumatol; 1991; 9 Suppl 6():37-40. PubMed ID: 1711944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective study.
    Truckenbrodt H; Häfner R
    Arthritis Rheum; 1986 Jun; 29(6):801-7. PubMed ID: 3718568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study.
    van der Meer A; Wulffraat NM; Prakken BJ; Gijsbers B; Rademaker CM; Sinnema G
    Clin Exp Rheumatol; 2007; 25(3):480-5. PubMed ID: 17631750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
    Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease flare after 7 year-remission of systemic type juvenile idiopathic arthritis: is growth hormone therapy a culprit or innocent bystander?
    Kim JY; Kim HS; Park SH
    Int J Rheum Dis; 2015 Mar; 18(3):377-8. PubMed ID: 24785656
    [No Abstract]   [Full Text] [Related]  

  • 31. Methotrexate/naproxen-associated severe hepatitis in a child with juvenile idiopathic arthritis.
    Ting TV; Hashkes PJ
    Clin Exp Rheumatol; 2007; 25(6):928-9. PubMed ID: 18173932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
    Kostik MM; Gaidar EV; Hynnes AY; Dubko MF; Masalova VV; Snegireva LS; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG
    Clin Exp Rheumatol; 2016; 34(4):714-8. PubMed ID: 27385618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting remission in juvenile rheumatoid arthritis with methotrexate treatment.
    Wallace CA; Sherry DD; Mellins ED; Aiken RP
    J Rheumatol; 1993 Jan; 20(1):118-22. PubMed ID: 8441141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of subcutaneous methotrexate.
    Balis FM; Mirro J; Reaman GH; Evans WE; McCully C; Doherty KM; Murphy RF; Jeffries S; Poplack DG
    J Clin Oncol; 1988 Dec; 6(12):1882-6. PubMed ID: 3199171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with response to methotrexate in systemic-onset juvenile chronic arthritis.
    Ravelli A; Ramenghi B; Di Fuccia G; Ruperto N; Zonta L; Martini A
    Acta Paediatr; 1994 Apr; 83(4):428-32. PubMed ID: 8025404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of methotrexate and azathioprine on the serum levels of IgA-alpha 1-antitrypsin complex in juvenile chronic arthritis.
    Lacki JK; Klama K; Michels H; Truckenbrodt H; Mackiewicz S; Muller W
    Braz J Med Biol Res; 1997 Jun; 30(6):763-7. PubMed ID: 9292114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension.
    Ruperto N; Lovell DJ; Cuttica R; Woo P; Meiorin S; Wouters C; Silverman ED; Balogh Z; Henrickson M; Davidson J; Foeldvari I; Imundo L; Simonini G; Oppermann J; Xu S; Shen YK; Visvanathan S; Fasanmade A; Mendelsohn A; Martini A; Giannini EH; ;
    Ann Rheum Dis; 2010 Apr; 69(4):718-22. PubMed ID: 20237125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis.
    Woo P; Southwood TR; Prieur AM; Doré CJ; Grainger J; David J; Ryder C; Hasson N; Hall A; Lemelle I
    Arthritis Rheum; 2000 Aug; 43(8):1849-57. PubMed ID: 10943876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone mass change during methotrexate treatment in patients with juvenile rheumatoid arthritis.
    Bianchi ML; Cimaz R; Galbiati E; Corona F; Cherubini R; Bardare M
    Osteoporos Int; 1999; 10(1):20-5. PubMed ID: 10501775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
    Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B
    Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.